Compounds > 5-fluoro-2,2'-cyclocytidine
Page last updated: 2024-09-03

5-fluoro-2,2'-cyclocytidine and razoxane

5-fluoro-2,2'-cyclocytidine has been researched along with razoxane in 1 studies

Compound Research Comparison

Studies
(5-fluoro-2,2'-cyclocytidine)		Trials
(5-fluoro-2,2'-cyclocytidine)		Recent Studies (post-2010)
(5-fluoro-2,2'-cyclocytidine)		Studies
(razoxane)		Trials
(razoxane)		Recent Studies (post-2010) (razoxane)
51082411556

Protein Interaction Comparison

ProteinTaxonomy5-fluoro-2,2'-cyclocytidine (IC50)razoxane (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 23.19

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brugarolas, A; Buesa, JM; Gracia Marco, M; Lacave, AJ; Valle Pereda, M1

Other Studies

1 other study(ies) available for 5-fluoro-2,2'-cyclocytidine and razoxane

ArticleYear
Phase I and II clinical study of anhydro-ara-5-fluorocytosine (AAFC) and ICRF-159 combination in adenocarcinoma of digestive origin.
    Cancer clinical trials, 1978,Winter, Volume: 1, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Ancitabine; Bone Marrow; Cytarabine; Digestive System Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Razoxane; Remission, Spontaneous

1978